Northwestern Medicine scientists have demonstrated that cancer cells – and not normal cells – can … more
By attaching a cancer-killer protein to white blood cells, Cornell biomedical engineers have demonstrated the … more
A team of scientists, led by principal investigator Paul S. Mischel, MD, a member of … more
Ludwig researchers have elucidated a key mechanism by which cancer cells change how they metabolize … more
A non-disease causing virus kills human breast cancer cells in the laboratory, creating opportunities for … more
RIVERSIDE, Calif. — Researchers at the University of California, Riverside have identified components in pomegranate juice that both inhibit the movement of cancer cells and weaken their attraction to a chemical signal that promotes the metast…
Researchers have identified a new member of the important B7 family of immune system “co-stimulators.” Co-stimulators are molecules that are capable of turning the immune system on or off — and in the process, profoundly affecting human health. Mayo Clinic researchers named this newest molecule B7-H4. It inhibits the action of T cells, the immune system warriors whose basic job is to attack invaders. Turning off T cells helps transplant patients accept foreign organs. But turning off T cells harms cancer patients — their tumors continue to grow without defensive attacks by T cells. The Mayo Clinic report appears in the June 17 issue of Immunity.
Researchers have generated a mouse model of a new type of tumor suppressor gene that triggers a rapidly advancing cancer that affects children. The discovery of the fast-onset cancers that result from inactivation of the gene and the technique used to generate the model will likely prove useful in studying genes involved in other forms of cancer.